Journal of Neuroimmune Pharmacology

, Volume 5, Issue 4, pp 566–573

Methamphetamine-Induced Behavioral and Physiological Effects in Adolescent and Adult HIV-1 Transgenic Rats

  • Marley D. Kass
  • Xiangqian Liu
  • Michael Vigorito
  • Linda Chang
  • Sulie L. Chang
ORIGINAL ARTICLE

Abstract

We recently reported that six consecutive days of treatment with a moderate dose of methamphetamine (METH) induced greater behavioral sensitization in adult HIV-1 transgenic (HIV-1 Tg) rats than in adult Fischer 344/NHsd (F344) non-transgenic, wild-type control animals. In the present study, we evaluated the effects of a moderate dose of METH on the brains of adolescent versus adult HIV-1 Tg male rats using both behavioral (METH-induced, stereotypic head movement) and physiological (rectal body temperature) parameters. We found that both the acute and behavior-sensitizing effects of METH were greater in HIV-1 Tg rats compared with controls and also in adolescent rats compared with adult animals, regardless of HIV-1 status. We determined that acute hyperthermic effects of METH as well as tolerance to METH-induced hyperthermia were greater in HIV-1 Tg rats than in controls. Taken together, these results suggest that both the neuroadaptations seen in HIV infection and the immaturity of the adolescent brain are associated with increased sensitivity to the psychoactive and behavior-sensitizing properties of METH. Thus, HIV-infected individuals and adolescents may be more vulnerable to the development of METH abuse and dependence than non-infected individuals and adults.

Keywords

methamphetamine HIV-1 adolescent brain hyperthermia 

References

  1. Abekawa T, Ohmori T, Koyama T (1997) Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine. Brain Res 767:34–44CrossRefPubMedGoogle Scholar
  2. Anderson SL, Teicher MH (2009) Desperately driven and no breaks: developmental stress exposure and subsequent risk for substance abuse. Neurosci Biobehav Rev 33:516–524CrossRefGoogle Scholar
  3. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna WE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799CrossRefPubMedGoogle Scholar
  4. Assis MA, Hansen C, Lux-Lantos V, Cancela LM (2009) Sensitization to amphetamine occurs simultaneously at immune level and in met-enkephalin of the nucleus accumbens and spleen: An involved NMDA glutamatergic mechanism. Brain Behav Immune 23:464–473CrossRefGoogle Scholar
  5. Baucum AJ, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE (2004) Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism. J Neurosci 24:3436–3443CrossRefPubMedGoogle Scholar
  6. Belcher AM, O’Dell SJ, Marshall JF (2006) A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition. Behav Brain Res 170:167–172CrossRefPubMedGoogle Scholar
  7. Berridge KC, Kringelbach ML (2008) Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology 199:457–480CrossRefPubMedGoogle Scholar
  8. Brown PL, Bae D, Kiyatkin EA (2007) Relationships between locomotor activation and alterations in brain temperature during selective blockade and simulation of dopamine transmission. Neuroscience 145:335–343CrossRefPubMedGoogle Scholar
  9. Callaway CW, Clark RF (1994) Hyperthermia in psychostimulant overdose. Ann Emerg Med 24:68–76CrossRefPubMedGoogle Scholar
  10. Carrico AW, Johnson MO, Morin SF, Remien RH, Riley ED, Hecht FM, Fuchs D (2008) Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy. Brain Behav Immune 22:1257–1262CrossRefGoogle Scholar
  11. Chang L, Ernst T, Speck O, Grob CS (2005) Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry 162:361–369CrossRefPubMedGoogle Scholar
  12. Crombag HS, Badiani A, Chan J, Dell’Orco J, Dineen SP, Robinson TE (2001) The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding. Neuropsychopharmacology 24:680–690CrossRefPubMedGoogle Scholar
  13. Dallmann R, Steinlechner S, von Hörsten S, Karl T (2006) Stress-induced hyperthermia in the rat: comparison of classical and novel recording methods. Lab Anim 40:186–193CrossRefPubMedGoogle Scholar
  14. Fasano A, Barra A, Nicosia P, Rinaldi F, Bria P, Bentivoglio AR, Tonioni F (2008) Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding. Drug Alcohol Depend 29:178–182CrossRefGoogle Scholar
  15. Feil J, Sheppard D, Fitzgerald PB, Yucel M, Lubman DI, Bradshaw JL (2010) Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci Biobehav Rev. doi:10.1016/j.neubiorev.2010.03.001
  16. Ferris MJ, Mactutus CF, Booze RM (2008) Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effects on the brain: current status of dopamine system vulnerability in neuroAIDS. Neurosci Biobehav Rev 32:883–909CrossRefPubMedGoogle Scholar
  17. Huevel OA, Werf YD, Verhoef KMW, de Witt S, Berendse HW, Wolters EC, Veltman DJ, Gorenewegen HJ (2009) Frontal–striatal abnormalities underlying behaviors in the compulsive–impulsive spectrum. J Neurol Sci 289(1):55–59Google Scholar
  18. Itzhak Y, Martin JL, Black MD, Ali SF (1998) Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization. Neuropharmacol 37:781–791CrossRefGoogle Scholar
  19. Itzhak Y, Marin JL, Ali SF (2002) Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry 26:1177–1183CrossRefPubMedGoogle Scholar
  20. Jernigan TL, Gamst AC, Archibald SL, Fennema-Notestine C, Rivera-Mindt M, Marcatte TL, Heaton RK, Ellis RS, Grant I (2005) Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 162:1461–1472CrossRefPubMedGoogle Scholar
  21. Kalechstein AD, Jentsch JD, Kantak KM (2008) Stimulant-associated cognitive abnormalities: mechanisms and impact on reward-related behavior and addiction. Drug Alcohol Depend 97:276–280CrossRefPubMedGoogle Scholar
  22. Kopinsky KL, Bao J, Lin YW (2007) Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report. Brain Behav Immun 21:428–441CrossRefGoogle Scholar
  23. LaShomb AL, Vigorito M, Chang SL (2009) Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol 15:14–24CrossRefPubMedGoogle Scholar
  24. Li C-sR, Sinha R (2008) Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction. Neurosci Biobehav Rev 32:581–597CrossRefPubMedGoogle Scholar
  25. Liu X, Chang L, Vigorito M, Kass M, Li H, Chang SL (2009) Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat. J Neuroimmune Pharmacol 4:309–316CrossRefPubMedGoogle Scholar
  26. Paus T, Keshavan M, Giedd JN (2008) Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 9:947–957PubMedGoogle Scholar
  27. Peng J, Vigorito M, Liu X, Zhou D, Wu X, Chang SL (2010) The HIV-1 transgenic rat as a model for HIV-1 infected individuals given HAART. J Neuroimmunol 218:94–101CrossRefPubMedGoogle Scholar
  28. Pruznak AM, Hong-Brown L, Lantry R, She P, Frost RA, Vary TC, Lang CH (2008) Skeletal and cardiac myopathy in HIV-1 transgenic rats. Am J Physiol Endocrinol Metab 295:E964–E973CrossRefPubMedGoogle Scholar
  29. Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O’Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M, Bryant J (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98:9271–9276CrossRefPubMedGoogle Scholar
  30. Riddle EL, Kokoshka JM, Wilkins DG, Hanson GR, Fleckenstein AE (2002) Tolerance to the neurotoxic effects of methamphetamine in young rats. Eur J Pharmacol 435:181–185CrossRefPubMedGoogle Scholar
  31. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive sensitization theory of addiction. Brain Res Rev 8:247–291CrossRefGoogle Scholar
  32. Robinson TE, Berridge KC (2001) Mechanisms of action of addictive stimuli: incentive-sensitization and addiction. Addiction 96:103–114CrossRefPubMedGoogle Scholar
  33. Robinson TE, Berridge KC (2004) Incentive-sensitization and drug ‘wanting’. Psychopharmacol 171:352–353CrossRefGoogle Scholar
  34. Robinson TE, Berridge KC (2008) The incentive-sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 363:3137–3146CrossRefPubMedGoogle Scholar
  35. Sanchez-Alavez M, Gombart LM, Huitron-Resendiz S, Carr JR, Wills DN, Berg G, Campbell IL, Gauvin DV, Henriksen SJ, Criado JR (2004) Physiological and behavioral effects of methamphetamine in a mouse model of endotoxemia: a preliminary study. Pharmacol Biochem Behav 77:365–370CrossRefPubMedGoogle Scholar
  36. Sekine Y, Minabe Y, Kawai M, Suzuki K, Iyo M, Isoda H, Sakahara H, Ashby CR, Takei N, Mori N (2002) Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms: a proton MRS study. Neuropsychopharmacology 27:453–461CrossRefPubMedGoogle Scholar
  37. Substance Abuse and Mental Health Services Administration (2009) Results from the 2008 national survey on drug use and health: National findings. Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434. Rockville, MD.Google Scholar
  38. Vigorito M, LaShomb AL, Chang SL (2007) Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2:319–328CrossRefPubMedGoogle Scholar
  39. Wang G-J, Chang L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127:2452–2458CrossRefPubMedGoogle Scholar
  40. Zakharova E, Leoni G, Kichko I, Izenwasser S (2009) Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats. Behav Brain Res 198:45–50CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Marley D. Kass
    • 1
  • Xiangqian Liu
    • 1
  • Michael Vigorito
    • 1
    • 2
  • Linda Chang
    • 3
  • Sulie L. Chang
    • 1
    • 4
  1. 1.Institute of NeuroImmune PharmacologySeton Hall UniversitySouth OrangeUSA
  2. 2.Department of PsychologySeton Hall UniversitySouth OrangeUSA
  3. 3.Department of Medicine, Division of Neurology, John A. Burns School of MedicineUniversity of Hawai`i at ManoaHonoluluUSA
  4. 4.Department of Biological SciencesSeton Hall UniversitySouth OrangeUSA

Personalised recommendations